Literature DB >> 23887845

Adjunctive medical therapies for acute stroke thrombolysis: is there a CLEAR-ER choice?

Andrew D Barreto, Claudia Pedroza, James C Grotta.   

Abstract

Entities:  

Keywords:  Bayes theorem; platelet glycoprotein GPIIb-IIIa complex; stroke; thrombolytic therapy

Mesh：

Substances：

Year:  2013        PMID： 23887845      PMCID： PMC3845499          DOI： 10.1161/STROKEAHA.113.001830

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  9 in total

1.  Toward evidence-based medical statistics. 1: The P value fallacy.

Authors:  S N Goodman
Journal:  Ann Intern Med       Date:  1999-06-15       Impact factor: 25.391

2.  Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.

Authors:  Duminda N Wijeysundera; Peter C Austin; Janet E Hux; W Scott Beattie; Andreas Laupacis
Journal:  J Clin Epidemiol       Date:  2008-10-23       Impact factor: 6.437

3.  A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.

Authors:  Mark Parsons; Neil Spratt; Andrew Bivard; Bruce Campbell; Kong Chung; Ferdinand Miteff; Bill O'Brien; Christopher Bladin; Patrick McElduff; Chris Allen; Grant Bateman; Geoffrey Donnan; Stephen Davis; Christopher Levi
Journal:  N Engl J Med       Date:  2012-03-22       Impact factor: 91.245

4.  Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial.

Authors:  Arthur M Pancioli; Opeolu Adeoye; Pamela A Schmit; Jane Khoury; Steven R Levine; Thomas A Tomsick; Heidi Sucharew; Claudette E Brooks; Todd J Crocco; Laurie Gutmann; Thomas M Hemmen; Scott E Kasner; Dawn Kleindorfer; William A Knight; Sharyl Martini; James S McKinney; William J Meurer; Brett C Meyer; Alexander Schneider; Phillip A Scott; Sidney Starkman; Steven Warach; Joseph P Broderick
Journal:  Stroke       Date:  2013-07-25       Impact factor: 7.914

5.  Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator.

Authors:  Andrei V Alexandrov; James C Grotta
Journal:  Neurology       Date:  2002-09-24       Impact factor: 9.910

Review 6.  Adjunctive and alternative approaches to current reperfusion therapy.

Authors:  Andrew D Barreto; Andrei V Alexandrov
Journal:  Stroke       Date:  2012-01-05       Impact factor: 7.914

7.  Ultrasound-enhanced thrombolysis for acute ischemic stroke: phase I. Findings of the CLOTBUST trial.

Authors:  Andrei V Alexandrov; Andrew M Demchuk; W Scott Burgin; David J Robinson; James C Grotta
Journal:  J Neuroimaging       Date:  2004-04       Impact factor: 2.486

8.  Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.

Authors:  Joseph P Broderick; Yuko Y Palesch; Andrew M Demchuk; Sharon D Yeatts; Pooja Khatri; Michael D Hill; Edward C Jauch; Tudor G Jovin; Bernard Yan; Frank L Silver; Rüdiger von Kummer; Carlos A Molina; Bart M Demaerschalk; Ronald Budzik; Wayne M Clark; Osama O Zaidat; Tim W Malisch; Mayank Goyal; Wouter J Schonewille; Mikael Mazighi; Stefan T Engelter; Craig Anderson; Judith Spilker; Janice Carrozzella; Karla J Ryckborst; L Scott Janis; Renée H Martin; Lydia D Foster; Thomas A Tomsick
Journal:  N Engl J Med       Date:  2013-02-07       Impact factor: 91.245

9.  The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial.

Authors:  Arthur M Pancioli; Joseph Broderick; Thomas Brott; Thomas Tomsick; Jane Khoury; Judy Bean; Gregory del Zoppo; Dawn Kleindorfer; Daniel Woo; Pooja Khatri; John Castaldo; James Frey; James Gebel; Scott Kasner; Chelsea Kidwell; Thomas Kwiatkowski; Richard Libman; Richard Mackenzie; Phillip Scott; Sidney Starkman; R Jason Thurman
Journal:  Stroke       Date:  2008-09-04       Impact factor: 7.914
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.